Natco Pharma Ltd. on Saturday said it has received an establishment inspection report from the U.S. drug regulator for its Kothur facility in Telangana.
"The United States Food and Drug Administration had conducted pre-approval inspection at the company's drug formulations facility in Kothur village during the period from March 2 to 6, 2020," Natco Pharma said in a filing to the BSE.
The EIR signifies successful closure of inspection by the regulator, it added.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
